Let’s Get Started On The Teladoc Health Inc (NYSE: TDOC) Stock Forecast.

In the last trading session, 3.99 million shares of the Teladoc Health Inc (NYSE:TDOC) were traded, and its beta was 0.96. Most recently the company’s share price was $13.74, and it changed around $0.44 or 3.31% from the last close, which brings the market valuation of the company to $2.33B. TDOC currently trades at a discount to its 52-week high of $30.41, offering almost -121.32% off that amount. The share price’s 52-week low was $12.85, which indicates that the current value has risen by an impressive 6.48% since then. We note from Teladoc Health Inc’s average daily trading volume that its 3-month average coming to 4.83 million.

Teladoc Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.55. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 3 recommended TDOC as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Teladoc Health Inc is expected to report earnings per share of -$0.46 for the current quarter.

Teladoc Health Inc (NYSE:TDOC) trade information

Instantly TDOC has showed a green trend with a performance of 3.31% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently down -36.24% year-to-date, but still up 4.65% over the last five days. On the other hand, Teladoc Health Inc (NYSE:TDOC) is -8.40% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $58.04, which translates to bulls needing to increase their stock price by 76.33% from its current value. Analyst projections state that TDOC is forecast to be at a low of $18 and a high of $150.

Teladoc Health Inc (TDOC) estimates and forecasts

Teladoc Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -25.57 percent over the past six months and at a 20.15% annual growth rate that is well above the industry average of 12.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -9.50% in revenue this quarter, and will report an increase of 25.00% in the next quarter. The year-over-year growth rate is expected to be 2.40%, up from the previous year.

Consensus estimates provided by 25 financial analysts predict the company will bring in an average of $637.29 million in revenue for the current quarter. 25 analysts expect Teladoc Health Inc to make $662.56 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $618.31 million and $649.19 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 3.10%. Forecasts for the next quarter put sales growth at 2.10%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 1.91%.